Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying

J E Schweinle1, M Nishiyasu

  • 1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.

Insights

Growth in sub-minimal inhibitory concentrations of cefmetazole (CMZ) renders serum-resistant bacteria sensitive to complement-mediated killing. This occurs due to increased bacterial hydrophobicity and enhanced formation of bactericidal membrane attack complexes containing poly-C9.

Area of Science:

  • Microbiology
  • Immunology
  • Bacteriology

Background:

  • Serum resistance is a key virulence factor for many bacterial pathogens.
  • Complement-mediated bactericidal activity is a crucial component of innate immunity.
  • Sub-minimal inhibitory concentrations (subMICs) of antibiotics can alter bacterial physiology.

Purpose of the Study:

  • To investigate if subMIC cefmetazole (CMZ) treatment can restore serum sensitivity to serum-resistant bacteria.
  • To elucidate the mechanisms by which CMZ affects bacterial susceptibility to complement.

Main Methods:

  • Growth of Salmonella montevideo SH5770 in subMIC cefmetazole (CMZ).
  • Measurement of 125I-C3 and 125I-C9 deposition on bacteria.
  • SDS-PAGE, autoradiography, indirect immunofluorescence, and ELISA for complement component analysis.
  • Assessment of bacterial hydrophobicity and cell wall integrity via electron microscopy.

Main Results:

  • CMZ-treated bacteria showed significantly increased deposition of C3 and C9 compared to untreated bacteria.
  • SDS-PAGE confirmed enhanced formation of complement membrane attack complexes (poly-C9) on CMZ-grown bacteria.
  • Bacterial hydrophobicity increased, and cell wall disruption/blebbing was observed after CMZ treatment.
  • The ratio of C3b:iC3b and the nature of the C3-bacterial bond remained unchanged.

Conclusions:

  • Growth in subMIC cefmetazole (CMZ) effectively renders serum-resistant Salmonella sensitive to complement-mediated killing.
  • CMZ treatment enhances bacterial susceptibility by increasing cell surface hydrophobicity, facilitating membrane attack complex (C5b-9) formation and stable insertion of poly-C9.
  • This study highlights a novel mechanism by which sub-antibiotic concentrations can modulate bacterial-host immune interactions.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...